This inventor holds 2 USPTO granted patents. Top assignees: Mitsubishi Chemical Industries Limited, Nippon Shinyaku Company, Ltd.. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 614 
2 out of 229 Years Active: 1978
Title: Innovations of Tatsuo Nomura
Introduction
Tatsuo Nomura is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of inflammation treatment. With a total of 2 patents, his work has garnered attention for its potential impact on health.
Latest Patents
Nomura's latest patents include "2-Aminomethyl-5-phenyloxazoles and the pharmaceutically acceptable salts." These compounds have been found to be effective for meliorating inflammation in warm-blooded animals. Another patent focuses on "2-Aminomethyl-5-phenyloxazoles and the pharmaceutically acceptable acid," which also demonstrates efficacy in treating inflammation.
Career Highlights
Throughout his career, Tatsuo Nomura has worked with prominent companies such as Mitsubishi Chemical Industries Limited and Nippon Shinyaku Company, Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Nomura has collaborated with notable coworkers, including Sho Inoue and Katsuya Ohata. Their combined efforts have further advanced the research and development of effective pharmaceutical solutions.
Conclusion
Tatsuo Nomura's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a significant inventor in the industry. His work continues to influence the treatment of inflammation in warm-blooded animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile